EVAXION BIOTECH A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.18 USD | +1.46% |
|
-3.02% | -39.04% |
| 26/04 | European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4% | MT |
| 17/04 | Evaxion Announces Phase 2 Clinical Trial Update | CI |
Chart calendar Evaxion Biotech A/S
809caeae71c47a187fda.c1IniybJythe4YyVS39BvMnrCXrIWyHmhK0yuUB5ttg.Bxps_RCIoLA4lu_4AjkW6o2HQx2xbEuM08FtzDVAzosaZUTdSp-wrAajwQ~00638213074869a97047737a8592db26
Upcoming events on Evaxion Biotech A/S
Past events on Evaxion Biotech A/S
| 16/04/2024 06:30 pm | Annual General Meeting |
| 02/04/2024 06:30 pm | Q4 2023 Earnings Call |
| 02/04/2024 | World Vaccine Congress |
| 27/03/2024 05:00 pm | Q4 2023 Earnings Release |
| 19/03/2024 06:30 pm | R&D Day |
| 07/03/2024 | MarketsandMarkets Next-Gen Immuno-Oncology Conference |
| 07/03/2024 | Biomarker and Companion Diagnostics Conference |
| 07/03/2024 | H.C. Wainwright Artificial Intelligence Based Drug Discovery & Development Virtual Conference |
| 06/03/2024 | Biologics World Nordics Conference |
| 28/02/2024 | Sachs Associates European Life Sciences CEO Forum |
| 27/02/2024 | Sachs Associates European Healthtech CEO Forum - Panel |
| 11/01/2024 07:30 pm | Extraordinary Shareholders Meeting |
| 08/01/2024 | J.P. Morgan Healthcare Conference |
| 20/12/2023 02:45 am | Q3 2023 Earnings Release |
| 10/12/2023 04:00 am | American Society of Hematology Meeting |
| 10/12/2023 04:00 am | American Society of Hematology Meeting |
| 14/11/2023 | Bio Markers Europe Conference |
| 09/11/2023 | NextGen Omics Congress |
| 08/11/2023 10:00 pm | Investor Meeting - Key Opinion Leader |
| 06/11/2023 | Bio-Europe Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 6,27 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -25,5 -26,0 1.96% | -24,6 -25,0 1.56% | -21,6 -22,0 1.9% | -10,6 |
|
EBIT Million USD | Released Forecast Spread | -10,9 | -16,6 -16,1 -3.18% | -25,8 -25,0 -3.16% | -25,3 -25,2 -0.37% | -22,2 -22,2 0.23% | -10,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -16,6 -16,1 -2.95% | -24,7 -24,6 -0.63% | -23,9 -23,0 -4.1% | -22,9 -22,8 -0.51% | -11,4 |
|
Net income Million USD | Released Forecast Spread | -11,2 | -15,0 -14,7 -2.18% | -24,5 -23,0 -6.81% | -23,2 -22,6 -2.52% | -22,1 -22,5 1.49% | -11,2 |
|
EPS USD | Released Forecast Spread | 0,00 | -9,70 -9,55 -1.57% | -12,6 -11,7 -7.69% | -9,80 -9,60 -2.08% | -0,81 -5,66 85.7% | -1,39 |
| Announcement Date | 22/10/20 | 06/04/21 | 22/03/22 | 27/04/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,72 -6,62 -16.66% | -6,40 -7,74 17.31% | -6,26 -7,17 12.74% | -6,08 -7,30 16.64% | -6,53 -6,52 -0.14% | -6,39 -5,59 -14.47% | -5,68 -5,73 0.88% | -5,76 -5,33 -8.06% | -4,36 -4,76 8.35% | -4,16 | -3,97 | -3,93 | -4,02 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,05 -6,43 -9.64% | -6,04 -7,06 14.45% | -4,95 -6,66 25.75% | -5,92 -5,82 -1.55% | -7,05 -6,10 -15.52% | -6,44 -5,84 -10.27% | -5,91 -5,73 -3.15% | -5,87 -5,43 -8.1% | -4,70 -4,81 2.32% | -4,31 | -4,12 | -4,08 | -4,17 |
|
Net income Million USD | Released Forecast Spread | -8,37 -6,45 -29.73% | -5,79 -7,44 22.15% | -4,77 -6,97 31.62% | -5,74 -6,58 12.81% | -6,87 -6,30 -9.1% | -6,24 -5,75 -8.63% | -5,68 -5,63 -1% | -5,68 -5,34 -6.37% | -4,52 -4,72 4.24% | -4,14 | -3,96 | -3,92 | -4,01 |
|
EPS USD | Released Forecast Spread | -3,90 -2,93 -32.95% | -2,50 -3,27 23.47% | -2,00 -3,00 33.33% | -2,40 -2,67 10% | -2,90 -2,63 -10.13% | -2,40 -2,40 0% | -2,10 -2,15 2.33% | -2,10 -1,95 -7.69% | -0,15 -1,60 90.63% | -0,56 | -0,50 | -0,51 | -0,52 |
| Announcement Date | 22/03/22 | 11/05/22 | 10/08/22 | 14/11/22 | 27/04/23 | 31/05/23 | 17/08/23 | 19/12/23 | 26/03/24 | - | - | - | - |
More events
Past sector events for Evaxion Biotech A/S
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- EVAX Stock
- Calendar Evaxion Biotech A/S
